FDA Amends Nonprescription Drug Regulations to Streamline Review Process

Summary

The Food and Drug Administration (FDA) has updated its rules for reviewing over-the-counter (OTC) medications, aiming to make the process more efficient and in line with the Sunscreen Innovation Act (SIA). The changes include new timelines and performance metrics for reviewing non-sunscreen OTC applications.